Diagnosis and diagnostic tests for fibromyalgia (syndrome)

Reumatismo

Volumn 64, Issue 4, 2012, Pages 194-205

  Hauser W ^a,b   Wolfe, F ^c  

^a KLINIKUM SAARBRÜCKEN   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

Author keywords

Diagnosis; Differential diagnosis; Fibromyalgia syndrome

Indexed keywords

AMERICAN COLLEGE OF RHEUMATOLOGY 2010 SYMPTOM SEVERITY SCALE; CHRONIC PAIN; CLINICAL ASSESSMENT; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FIBROMYALGIA; FIBROMYALGIA SURVEY QUESTIONNAIRE; HUMAN; INSTRUMENT VALIDATION; MEDICAL EXAMINATION; MEDICAL HISTORY; OCCULT BLOOD TEST; PAIN ASSESSMENT; PHYSICAL EXAMINATION; POLYSYMPTOMATIC DISTRESS SCALE; QUESTIONNAIRE; REVIEW; SOMATOFORM DISORDER;

EID: 84867185338     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: 10.4081/reumatismo.2012.194     Document Type: Review

References (41)

1. Wolfe F. Fibromyalgia wars. J Rheumatol. 2009; 36: 671-8.
2. Wolfe F, Häuser W. Fibromyalgia diagnosis and diagnostic criteria. Ann Med. 2011; 43: 495-502.
3. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990; 33: 160-72.
4. Yunus M, Masi AT, Calabro JJ, et al. Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 1981; 11: 151-71.
5. Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010; 62: 600-10.
6. Wolfe F, Clauw DJ, Fitzcharles MA, et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol. 2011; 38: 1113-22.
7. Häuser W, Jung E, Erbslöh-Möller BF, et al. Validation of the fibromyalgia survey questionnaire within a cross-sectional survey. PLOS One. 2012; 7: e37504.
8. Häuser W, Bernardy K, Wang H, Kopp I. Reports of methods. Schmerz 2012; 26: in press
9. Eich W, Häuser W, Arnold B, et al. Definition, classification, clinical diagnosis and prognosis of fibromyalgia syndrome. Schmerz. 2012; 26: in press.
10. Branco JC, Bannwarth B, Failde I, Abello Carbonell J, Blotman F, Spaeth M, et al.Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum. 2010; 39: 448-53.
11. Smythe HA, Moldofsky H. Two contributions to under 13. standing of the 'fibrositis' syndrome. Bull Rheum Dis. 1977; 28: 928-31.
12. Wolfe F. Stop using the American College of Rheumatology criteria in the clinic. J Rheu-matol. 2003; 30: 1671-2.
13. Okifuji A, Turk DC, Sinclair JD, Starz TW, Marcus DA. A standardized manual tender point survey. I. Development and determination of a threshold point for the identification of positive tender points in fibromyalgia syndrome. J Rheumatol. 1997; 24: 377-83.
14. Wolfe F. The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic. Ann Rheum Dis. 1997; 56: 268-71.
15. Gracely RH. A pain psychologist's view of tenderness in fibromyalgia. J Rheumatol. 2007; 34: 912-3.
16. Turk DC, Flor H. Primary fibromyalgia is greater than tender points: toward a multiaxial taxonomy. J Rheumatol. 1989; 19: 80-6.
17. World Health Organisation. International Classification of Diseases Version 2007. Available from: www.who.int/classifications/apps/icd/icd10online/?gm70.htm+m797
18. Sommer C, Häuser W, Burgmer M, et al. Etiology and pathophysiology of fibromyalgia syndrome. Schmerz. 2012; 26: in press.
19. Leiber B. Die klinischen Syndrome. 1990, Stuttgart, Urban & Schwarzenberg.
20. Hunt IM, Silman AJ, Benjamin S, et al. The prevalence and associated features of chronic widespread pain in the community using the "Manchester" definition of chronic widespread pain. Rheumatology. 1999; 38: 275-9.
21. Bennett R. Fibromyalgia, chronic fatigue syndrome, and myofascial pain. Curr Opin Rheu-matol. 1998; 10: 95-103.
22. Häuser W, Hayo S, Biewer W, et al. Diagnosis of fibromyalgia syndrome-a comparison of Association of the Medical Scientific Societies in Germany, survey, and American College of Rheumatology criteria. Clin J Pain. 2010; 26: 505-11.
23. Katz RS, Wolfe F, Michaud K. Fibromyalgia diagnosis: a comparison of clinical, survey, and American College of Rheumatology criteria. Arthritis Rheum. 2006; 5: 169-76.
24. Häuser W, Kühn-Becker H, von Wilmoswky H, et al. Demographic and clinical features of patients with fibromyalgia syndrome of different settings: a gender comparison. Gend Med. 2011; 8: 116-25.
25. Mourão AF, Blyth FM, Branco JC. Generalised musculoskeletal pain syndromes. Best Pract Res Clin Rheumatol. 2010; 24: 829-40.
26. Yunus MB, Aldag JC. The concept of incomplete fibromyalgia syndrome: comparison of incomplete fibromyalgia syndrome with fibro-myalgia syndrome by 1990 ACR classification criteria and its implications for newer criteria and clinical practice. J Clin Rheumatol. 2012; 18: 71-5.
27. Croft P, Burt J, Schollum J, Thomas E, Mac-farlane G, Silman A. More pain, more tender points: is fibromyalgia just one end of a continuous spectrum? Ann Rheum Dis. 1996; 55: 482-5.
28. Häuser W, Schmutzer G, Brähler E, Glaesmer H. A cluster within the continuum of biopsy-chosocial distress can be labeled "fibromyal-gia syndrome" - evidence from a representative German population survey. J Rheumatol. 2009; 36: 2806-12.
29. Bennett RM, Friend R, Jones KD, et al. The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther. 2009; 11: R120.
30. Schaefer C, Chandran A, Hufstader M, et al. The comparative burden of mild, moderate and severe Fibromyalgia: results from a cross-sectional survey in the United States. Health Qual Life Outcomes. 2011; 9: 71.
31. Yunus MB. The prevalence of fibromyalgia in other chronic pain conditions. Pain Res Treat. 2012; 2012: 584573.
32. Creed FH, Davies I, Jackson J, et al The epidemiology of multiple somatic symptoms. J Psychosom Res. 2012; 72: 311-7.
33. Perrot S, Bouhassira D, Fermanian J. Cercle d'Etude de la Douleur en Rhumatologie. Development and validation of the Fibromyalgia Rapid Screening Tool (FiRST). Pain. 2010; 150: 250-6.
34. Arnold LM, Stanford SB, Welge JA, Crofford LJ. Development and testing of the fibromyal-gia diagnostic screen for primary care. J Wo-mens Health (Larchmt). 2012; 21: 231-9.
35. Köllner V, Bernardy K, Sommer C, Häuser W. [Diagnosis and therapy of fibromyalgia syndrome.] [Article in German]. Dtsch Med Wochenschr. 2009; 134: 1163-74.
36. Russell IJ, Raphael KG. Fibromyalgia syndrome: presentation, diagnosis, differential diagnosis, and vulnerability. CNS Spectr. 2008; 13 (Suppl. 5): 6-11.
37. Kroenke K, Spitzer RL, Jannett BW, et al. An Ultra-brief screening scale for anxiety and depression: The PHQ-4. Psychosomatics. 2009; 50: 613-21.
38. Köllner V, Häuser W, Bernardy BH, et al. Sys-temtaic review, meta-analysis and guideline: Psychotherapy in patients with fibromyalgoia syndrome. Schmerz. 2012; 26: in press.
39. Shir Y, Fitzcharles MA. Should rheuma-tologists retain ownership of fibromyalgia? J Rheumatol. 2009; 36: 667-70.
40. Choy E, Perrot S, Leon T, et al. A patient survey of the impact of fibromyalgia and the journey to diagnosis. BMC Health Serv Res. 2010; 10: 102.
41. Henningsen P, Zimmermann T, Sattel H. Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review. Psychosom Med. 2003; 65: 528-33.